Pulmonary Neoplasms Clinical Trial
Official title:
Clinical Effectiveness of a Balloon Covered Sheath as a Guide Sheath in Endobronchial Ultrasound Guided Diagnosis of Peripheral Lung Lesions
Verified date | March 2007 |
Source | Chang Gung Memorial Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Taiwan: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to examine the usefulness of a balloon covered sheath as a guide sheath in endobronchial ultrasound guided transbronchial biopsy and bronchial brushing cytology for diagnosis of peripheral lung lesions
Status | Completed |
Enrollment | 180 |
Est. completion date | March 2009 |
Est. primary completion date | March 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients with peripheral pulmonary lesions who are going to receive bronchoscopy Exclusion Criteria: - endobronchial abnormalities - associated lung parenchyma changes, ex. lung collapse or atelectasis |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Taiwan | Department or Chest Medicine, Chang Gung Memorial Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
Chang Gung Memorial Hospital | National Science Council, Taiwan |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the diagnostic efficiency of flexible bronchoscopy(FB) in peripheral lung lesions(PPLs) | 1 year | Yes | |
Secondary | complications, including bleeding, pneumothorax, respiratory failure, | 1 year | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
Completed |
NCT05011890 -
Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
|
N/A | |
Completed |
NCT00290953 -
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide
|
Phase 2/Phase 3 | |
Completed |
NCT00132639 -
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)
|
Phase 2 | |
Terminated |
NCT00241267 -
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease
|
N/A | |
Terminated |
NCT02673021 -
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
|
N/A | |
Terminated |
NCT00232128 -
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
|
N/A | |
Completed |
NCT00042679 -
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.
|
Phase 2 | |
Not yet recruiting |
NCT05857995 -
Precision Lung Cancer Survivorship Care Intervention
|
N/A | |
Recruiting |
NCT04699188 -
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
|
Phase 1/Phase 2 | |
Completed |
NCT02410603 -
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
|
||
Recruiting |
NCT02549638 -
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
|
||
Completed |
NCT02483052 -
RejuvenAir Lobectomy for Safety and Histology
|
Phase 1/Phase 2 | |
Completed |
NCT02370303 -
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
|
||
Completed |
NCT01470248 -
Study of Arsenic Trioxide in Small Cell Lung Cancer
|
Phase 2 |